Picton Mahoney Asset Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Other funds holding EW
Picton Mahoney Asset Management's EW Position: Q2 2025 in Review
Picton Mahoney Asset Management sold out of Edwards Lifesciences (EW) in Q2 2025, closing a stake of 63 shares — an estimated $4K sold.
Picton Mahoney Asset Management first reported a position in EW in Q4 2015 and held it in 15 quarters. The position peaked at $51.8M in Q3 2016. 1,260 funds tracked by Wall St. Rank hold EW as of Q2 2025.
- Picton Mahoney Asset Management reported no remaining Edwards Lifesciences position as of Q2 2025 after selling out during the quarter.
- Picton Mahoney Asset Management sold 63 Edwards Lifesciences shares in Q2 2025, an estimated $4K.
- Picton Mahoney Asset Management first reported a position in Edwards Lifesciences in Q4 2015 and held it in 15 quarters.
- Picton Mahoney Asset Management's Edwards Lifesciences position peaked at $51.8M in Q3 2016.
- 1,260 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2025.
Based on Picton Mahoney Asset Management's 13F filing for Q2 2025, filed 12 Aug 2025.